Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India ETF BSE Sensex Next 50 | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | Nippon India | Nippon India |
| NAV | ₹93.7420 | ₹235.6824 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 7.3 years | 7.8 years |
| Expense ratio | 0.3% | 0.3% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| Nippon India ETF BSE Sensex Next 50 | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| 1 month | +7.69% | +5.97% |
| 3 months | −0.74% | −2.55% |
| 6 months | +6.50% | +1.72% |
| YTD | +2.53% | +2.66% |
| 1 year | +2.36% | +2.08% |
| 3 years (CAGR) | +15.60% | +13.87% |
| 5 years (CAGR) | +13.15% | +14.66% |
| 10 years (CAGR) | — | — |
| Since launch | +17.05% | +18.99% |
Risk
| Nippon India ETF BSE Sensex Next 50 | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Volatility | 18.5% | 18.3% |
| Downside volatility | 12.2% | 12.4% |
| Sharpe | 0.49 | 0.40 |
| Sortino | 0.75 | 0.59 |
| Calmar | 0.75 | 0.66 |
| Return / risk | 0.84 | 0.76 |
| Deepest fall | −38.30% | −38.35% |
| Days to recover | 239 | 228 |
| Below its high | −1.19% | −3.21% |
Against benchmark
| Nippon India ETF BSE Sensex Next 50 | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Alpha | — | +0.00% |
| Beta | — | 1.00 |
| R² | — | 100.0% |
| Up capture | — | 100.0% |
| Down capture | — | 100.0% |
| Tracking error | — | 0.0% |
| Information ratio | — | — |
| Treynor | — | 0.06 |
Consistency
| Nippon India ETF BSE Sensex Next 50 | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Best 1-year | +99.69% | +116.74% |
| Middle 1-year | +12.83% | +14.06% |
| Worst 1-year | −9.67% | −33.73% |
| 1-year periods with a loss | 12.2% | 11.6% |
| Middle 3-year | +21.20% | +24.17% |
| Positive months | 69.4% | 66.7% |
| Best day | +4.88% | +3.95% |
| Worst day | −6.38% | −7.10% |
| Worst 5% day | −1.81% | −2.00% |
| Positive days | 56.8% | 57.1% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| Nippon India ETF BSE Sensex Next 50 | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| 5-year XIRR | +13.91% | +14.79% |
| 5-year value | ₹8,56,344 | ₹8,75,434 |
| 3-year XIRR | +8.22% | +7.85% |
| 1-year XIRR | +8.32% | +6.18% |
Holdings overlap i
| Nippon India ETF BSE Sensex Next 50 | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Nippon India ETF BSE Sensex Next 50 | — | 30% |
| Nippon India ETF Nifty Midcap 150 | 30% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India ETF BSE Sensex Next 50 | Nippon India ETF Nifty Midcap 150 |
|---|---|---|
| The Federal Bank Limited | 3.22% | 2.16% |
| Coforge Limited | 2.69% | 1.83% |
| The Indian Hotels Company Limited | 2.73% | 1.83% |
| One 97 Communications Limited | 2.67% | 1.81% |
| Hero MotoCorp Limited | 2.51% | 1.72% |
| Persistent Systems Limited | 2.50% | 1.69% |
| IndusInd Bank Limited | 2.09% | 1.42% |
| AU Small Finance Bank Limited | 1.85% | 1.29% |
| Lupin Limited | 1.85% | 1.25% |
| Indus Towers Limited | 1.86% | 1.25% |
| IDFC First Bank Limited | 1.81% | 1.23% |
| Dixon Technologies (India) Limited | 1.74% | 1.18% |
| Info Edge (India) Limited | 1.73% | 1.18% |
| Marico Limited | 1.62% | 1.09% |
| Ashok Leyland Limited | 1.55% | 1.06% |
| Suzlon Energy Limited | 1.56% | 1.06% |
| United Spirits Limited | 1.47% | 1.01% |
| ICICI Lombard General Insurance Company Limited | 1.46% | 0.99% |
| REC Limited | 1.34% | 0.92% |
| PB Fintech Limited | 1.35% | 0.91% |
| SRF Limited | 1.29% | 0.87% |
| Shree Cement Limited | 1.17% | 0.79% |
| Yes Bank Limited | 1.01% | 0.68% |
| Havells India Limited | 0.97% | 0.66% |
Sectors and company size
| Nippon India ETF BSE Sensex Next 50 | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Large companies | 57.8% | 5.9% |
| Mid companies | 42.2% | 90.7% |
| Small companies | — | 2.5% |
| Top 10 holdings | 30.8% | 18.4% |
| Largest sector | Banks 15% | Pharmaceuticals & Biotechnology 10% |